Evidence map›Paper›PMID 36697833›Full record

ArticleNature2023

Author Correction: The evolutionary history of 2,658 cancers.

Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C Dentro, Santiago Gonzalez, Daniel Rosebrock, Thomas J Mitchell, Yulia Rubanova, Pavana Anur, Kaixian Yu and 38 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. KRAS: the Achilles' heel of pancreas cancer biology.The Journal of clinical investigation · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

48 authors.

Moritz Gerstung *European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK. moritz.gerstung@ebi.ac.uk.
Clemency Jolly *The Francis Crick Institute, London, UK.
Ignaty Leshchiner *Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Stefan C Dentro *Wellcome Sanger Institute, Cambridge, UK.
Santiago Gonzalez *European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Daniel RosebrockBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Thomas J MitchellWellcome Sanger Institute, Cambridge, UK.
Yulia RubanovaUniversity of Toronto, Toronto, Ontario, Canada.
Pavana AnurMolecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
Kaixian YuThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Maxime TarabichiWellcome Sanger Institute, Cambridge, UK.
Amit DeshwarUniversity of Toronto, Toronto, Ontario, Canada.
Jeff WintersingerUniversity of Toronto, Toronto, Ontario, Canada.
Kortine KleinheinzGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Ignacio Vázquez-GarcíaWellcome Sanger Institute, Cambridge, UK.
Kerstin HaaseThe Francis Crick Institute, London, UK.
Lara JermanEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
Subhajit SenguptaNorthShore University HealthSystem, Evanston, IL, USA.
Geoff MacintyreCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Salem MalikicSimon Fraser University, Burnaby, British Columbia, Canada.
Nilgun DonmezSimon Fraser University, Burnaby, British Columbia, Canada.
Dimitri G LivitzBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Marek CmeroUniversity of Melbourne, Melbourne, Victoria, Australia.
Jonas DemeulemeesterThe Francis Crick Institute, London, UK.
Steven SchumacherBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Yu FanThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xiaotong YaoWeill Cornell Medicine, New York, NY, USA.
Juhee LeeUniversity of California Santa Cruz, Santa Cruz, CA, USA.
Matthias SchlesnerGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Paul C BoutrosUniversity of Toronto, Toronto, Ontario, Canada.
David D BowtellPeter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Hongtu ZhuThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gad GetzBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Marcin ImielinskiWeill Cornell Medicine, New York, NY, USA.
Rameen BeroukhimBroad Institute of MIT and Harvard, Cambridge, MA, USA.
S Cenk SahinalpVancouver Prostate Centre, Vancouver, British Columbia, Canada.
Yuan JiNorthShore University HealthSystem, Evanston, IL, USA.
Martin PeiferUniversity of Cologne, Cologne, Germany.
Florian MarkowetzCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Ville MustonenUniversity of Helsinki, Helsinki, Finland.
Ke YuanCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Wenyi WangThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Quaid D MorrisUniversity of Toronto, Toronto, Ontario, Canada.
PCAWG Evolution & Heterogeneity Working Group
Paul T SpellmanMolecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
David C WedgeBig Data Institute, University of Oxford, Oxford, UK.
Peter Van LooThe Francis Crick Institute, London, UK. peter.vanloo@crick.ac.uk.
PCAWG Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36697833
PMCPMC9931577

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.